Goodwill Pharma Orvos-, es Gyogyszertudomanyi Nyilvanosan Mukodo Reszvenytarsasag (BUSE: GOODWILLPHRM)
Health Care · Pharmaceuticals · HU
Ft510.00
+9.91% today · -40.0% 1Y
Public summary
A free snapshot of Goodwill Pharma Orvos-, es Gyogyszertudomanyi Nyilvanosan Mukodo Reszvenytarsasag, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Goodwill Pharma Orvos-, es Gyogyszertudomanyi Nyilvanosan Mukodo Reszvenytarsasag (BUSE: GOODWILLPHRM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $164.28M.
Over the last twelve months the share price has lost 40.0%, trading between 460.00 and 4.10K.
Tweenvest scores Goodwill Pharma Orvos-, es Gyogyszertudomanyi Nyilvanosan Mukodo Reszvenytarsasag across four factors: quality 87/100, value 70/100. Its strongest factor is quality.
GOODWILLPHRM price history
Key figures
- Market cap
- $164.28M
- Revenue (TTM)
- $21.27M
- P/E
- 78.10
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -0.21
- 52-week high
- Ft4,100.00
- 52-week low
- Ft460.00
- Avg volume (3M)
- —
- Shares outstanding
- 107.18M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| HLB Pharmaceutical Co., Ltd.KOSDAQ: A047920 | $167.77M | ₩6,830.00 | +0.44% |
| Mecure Industries PLCNGSE: MECURE | $167.37M | ₦56.20 | 0.00% |
| Korea United Pharm Inc.KOSE: A033270 | $166.65M | ₩15,590.00 | -0.57% |
| Kahira Pharmaceuticals & Chemical Industries CompanyCASE: CPCI | $166.46M | EGP595.62 | -0.45% |
| Alar Pharmaceuticals Inc.TPEX: 6785 | $163.78M | NT$80.70 | -0.25% |
| BioVersys AGSWX: BIOV | $163.75M | CHF23.40 | -2.09% |
| Binh Dinh Pharmaceutical and Medical Equipment Joint Stock CompanyHOSE: DBD | $163.49M | ₫44,500.00 | +1.95% |
| MPH Health Care AGDB: 93M1 | $162.43M | €34.60 | +5.17% |